Stem Cells: A Revolution in Parkinson Treatment
Parkinson disease affects over 10 million people worldwide, causing tremors, muscle rigidity, and movement difficulties. Current treatments only manage symptoms without curing the disease. However, the latest stem cell research is opening a promising new path.
Breakthrough from Kyoto University
A research team at Kyoto University (Japan), led by Professor Jun Takahashi, conducted clinical trials transplanting induced pluripotent stem cells (iPSCs) into the brains of Parkinson patients. Results after 2 years of monitoring showed that newly created dopamine cells survived and functioned in the patients brains, significantly improving motor capabilities.
Challenges Ahead
Despite promising results, many challenges remain: risk of tumor formation from stem cells, immune rejection, estimated cost of $200,000-$500,000 per case, and the need for Phase III clinical trials with larger patient groups. Experts expect this method could be clinically approved by 2030-2035.
In Vietnam, the Stem Cell Institute (Vietnam National University HCMC) is also conducting preclinical research on stem cell applications in neurological diseases, opening hope for tens of thousands of domestic Parkinson patients.
